Clinical Trials in Phoenix

Showing 13441-13460 of 16,646 trials

The Jetstream G3™ Calcium Study

NCT01273623

To investigate the treatment effects with the Jetstream G3 System in moderate to severely calcified peripheral artery disease in the common femoral, superficial femoral or popliteal arteries using intravascular ultrasound (IVUS).

Peripheral Arterial Disease

Boston Scientific Corporation55 participantsStarted Jan 2011

Phoenix, Arizona, United States • Atlanta, Georgia, United States • Detroit, Michigan, United States +2 more locations

TERMINATEDPhase 3< 1 mile

S9908: Glutamine in Treating Mucositis Caused by Radiation Therapy in Patients With Newly Diagnosed Cancer of the Mouth or Throat

NCT00006994

RATIONALE: Glutamine may be effective in decreasing side effects, such as inflammation of the mouth and throat, caused by radiation therapy. The effectiveness of glutamine for mucositis is not yet known. PURPOSE: Randomized phase III trial to determine the effectiveness of glutamine in treating patients who develop mucositis following radiation therapy for newly diagnosed cancer of the mouth or throat.

SWOG Cancer Research Network23 participantsStarted Nov 2001

Mobile, Alabama, United States • Phoenix, Arizona, United States • Phoenix, Arizona, United States +104 more locations

The Jetstream G3™ Calcium Study

S9908: Glutamine in Treating Mucositis Caused by Radiation Therapy in Patients With Newly Diagnosed Cancer of the Mouth or Throat

Find Trials by Condition in Phoenix

Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer

Computer Planned Radiation Therapy Plus Chemotherapy in Treating Patients With Glioblastoma Multiforme

Radiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate Cancer

Efficacy and Safety Study of Benralizumab Added to Medium-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma

Randomized Study Comparing the Efficacy and Safety of Varenicline Tartrate to Placebo in Smoking Cessation When Subjects Are Allowed to Set Their Own Quit Date

Cancer Vaccine Study for Unresectable Stage III Non-small Cell Lung Cancer (START)

S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer

BI 207127 / Faldaprevir Combination Therapy in Hepatic Impairment (Child-Pugh B) Patients With Genotype 1b Chronic Hepatitis C Infection: HCVerso3

Tube Versus Trabeculectomy (TVT) Study

Tofacitinib Ointment For Chronic Plaque Psoriasis

Ganitumab and Gemcitabine Hydrochloride Followed by Radiation Therapy, Ganitumab, Capecitabine, and Maintenance Therapy in Treating Patients With Locally Advanced Cancer of the Pancreas

Pediatric Safety and Immunogenicity Study of Cell-Culture Derived and Egg-based Subunit Influenza Vaccines in Healthy Children and Adolescents

S9924 R115777 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Effects of Ventavis in Patients With Pulmonary Hypertension (PH) Secondary to Chronic Obstructive Pulmonary Disease (COPD)

Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer

Safety and Immunogenicity of PanBlok Influenza Vaccine in Healthy Adults

Study of KB004 in Subjects With Hematologic Malignancies (Myelodysplastic Syndrome, MDS, Myelofibrosis, MF)

Vitamin A, Stool Microbiota and Vaccine Response in Bangladeshi Infants